Varaico: Literature-Extracted Genetic Variants

Gene:SLC19A3
Variant:p.N173D
Back to variants list

SLC19A3

NM_025243.4:p.N173D

Associated Papers

An unusually mild case of biotin-thiamine-responsive basal ganglia disease.

Lail G et al.

Molecular Genetics and Metabolism Reports, 2023

Biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of cases in Kuwait with novel variants.

Aburezq M et al.

Orphanet Journal of Rare Diseases, 2023

Report of the Largest Chinese Cohort With SLC19A3 Gene Defect and Literature Review.

Wang J et al.

Frontiers in Genetics, 2021

Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: a pilot study toward newborn screening.

Alfadhel M et al.

Annals of Clinical and Translational Neurology, 2019

Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies.

Marcé-Grau A et al.

Journal of Inherited Metabolic Disease, 2019

SLC19A3 Gene Defects Sorting the Phenotype and Acronyms: Review.

Alfadhel M et al.

Neuropediatrics, 2018

Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease.

Whitford W et al.

Cold Spring Harbor Molecular Case Studies, 2017

Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors.

Ortigoza-Escobar JD et al.

Annals of Neurology, 2017

Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data.

Ferreira CR et al.

American Journal of Medical Genetics. Part A, 2017

Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.

Reid ES et al.

Brain : a Journal of Neurology, 2016

27604308 (PubMed )
Supplement: aww221_supplementary_data.zip › brain-2016-00692-File005.pdf

Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.

Gerards M et al.

Brain : a Journal of Neurology, 2014

Treatable Leigh-like encephalopathy presenting in adolescence.

Fassone E et al.

Bmj Case Reports, 2013

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."